Trials / Completed
CompletedNCT01675427
A Study on the Correlation Between Interleukin 28B Genotypes With Clinical and Demographic Characteristics in Treatment-Naïve and Treatment-Experienced Patients With Chronic Hepatitis C
An International, Multi-Center Study Evaluating the Correlation of IL28B Genotypes With Patient Demographics and Disease Characteristics in Patients With Chronic Hepatitis C
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 4,766 (actual)
- Sponsor
- Hoffmann-La Roche · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This multicenter study will evaluate the correlation of interleukin 28B (IL28B) genotypes with disease characteristics and demographics in treatment-naïve and treatment-experienced chronic hepatitis C patients, including patients with HIV co-infection. There will be a single study visit for testing.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Interleukin 28B testing | Blood sampling for ILB28 genotyping |
Timeline
- Start date
- 2011-08-01
- Primary completion
- 2013-10-01
- Completion
- 2013-10-01
- First posted
- 2012-08-30
- Last updated
- 2015-08-26
- Results posted
- 2015-06-08
Locations
210 sites across 31 countries: United States, Argentina, Belgium, Chile, Egypt, Estonia, France, Germany, Greece, Italy, Kuwait, Latvia, Lebanon, Lithuania, Mexico, North Macedonia, Oman, Pakistan, Peru, Portugal, Qatar, Romania, Serbia, Slovakia, Sweden, Switzerland, Syria, Taiwan, Turkey (Türkiye), United Arab Emirates, Venezuela
Source: ClinicalTrials.gov record NCT01675427. Inclusion in this directory is not an endorsement.